A multicentric outbreak of Candida auris in Mexico: 2020 to 2023

Candida auris, an emerging multidrug-resistant yeast, has become a global concern due to its association with nosocomial outbreaks and resistance to antifungal medications. The COVID-19 pandemic has exacerbated the situation, with several outbreaks reported worldwide, including in Mexico. We describ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of infection control 2024-12, Vol.52 (12), p.1384-1389
Hauptverfasser:	la Garza, Patricia Rodríguez-de, Cruz-de la Cruz, Carlos de la, Bejarano, José Iván Castillo, Romo, Alicia Estela López, Delgado, Jorge Vera, Ramos, Beatriz Aguilar, Neira, Mirna Natalia Martínez, Rodríguez, Daniel Siller, Rodríguez, Héctor Mauricio Sánchez, Selvera, Omar Alejandro Rangel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antifungal Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Antifungal resistance Candida auris Candidiasis - drug therapy Candidiasis - epidemiology Candidiasis - microbiology Candidiasis, Invasive Colonization COVID-19 - epidemiology Cross Infection - epidemiology Cross Infection - microbiology Disease Outbreaks Female Fluconazole - pharmacology Fluconazole - therapeutic use Humans Infection Infection control Male Mexico - epidemiology Middle Aged Retrospective Studies SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!